VRDN
NASDAQ · Biotechnology
Viridian Therapeutics Inc
$23.59
+1.08 (+4.80%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-21.52%
1Y
+39.67%
YTD
-23.11%
Open$22.98
Previous Close$22.51
Day High$23.61
Day Low$22.53
52W High$34.29
52W Low$13.18
Volume—
Avg Volume1.92M
Market Cap2.44B
P/E Ratio—
EPS$-3.96
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$31.51
Below
SMA 200
$22.43
Above
RSI (14)
17.6
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+170.6% upside
Current
$23.59
$23.59
Target
$63.84
$63.84
$43.31
$63.84 avg
$68.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 86.26M | 891.8K | 430.67M |
| Net Income | -417,094,962 | -725,406,968 | -19,976,292 |
| Profit Margin | -483.6% | -84,917.7% | -4.6% |
| EBITDA | -441,811,548 | -846,793,579 | -30,128,222 |
| Free Cash Flow | — | — | -23,390,816 |
| Rev Growth | +242.1% | -53.3% | -2.2% |
| Debt/Equity | 0.12 | 0.03 | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |